Categories: News Reports

Three Wockhardt drugs suspended

MUMBAI, APRIL 25, 2014:

Drugmaker Wockhardt has been asked by authorities in Himachal Pradesh to stop selling three drugs, the company said, without giving reasons.

In a statement to the stock exchange, the company said the HP drug controller has suspended the manufacture, sale or distribution of fixed dose combination drugs – Dicyclomine Hydrochloride IP 10mg (for irritable bowel syndrome), Tramadol Hydrochloride (for pain) IP 50mg and Acetamenophen IP 325mg (for pain and fever).

Wockhardt said it would file an appeal before the State Government to get the suspension revoked. Business Line

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

1 day ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago